Antonio Vergara, head of Roche Diagnostics Latin America, and Rolf Hoenger, head of Roche Pharma Latin America: “For the last two years, health care has become a major priority for both the public and private sectors in Latin America. While this has been a tremendous opportunity to highlight how smart investment in health can benefit social development and economic growth, access to quality care services continues to be a challenge for a large portion of the population, especially in Latin America, leaving too many patients vulnerable. According to the Pan American Health Organization, to improve the performance of health systems in the region, countries need to increase their investment in health care to at least 6 percent of their GDP and allocate at least 30 percent of that value to primary care services. Not only do efficient care services guarantee people’s well-being and shield our countries against the multi-layered impact of emergencies such as the Covid-19 pandemic…”